These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3245180)
61. [Differentiated use of neuroleptics in treatment of myocardial infarct]. Zaitsev VP Klin Med (Mosk); 1975 Jul; 53(7):61-5. PubMed ID: 1206995 [No Abstract] [Full Text] [Related]
62. Beta-blockade after myocardial infarction: is prolonged treatment feasible? Hamilton I; Connacher AA; Bouchier IA Scott Med J; 1987 Dec; 32(6):166. PubMed ID: 3449944 [No Abstract] [Full Text] [Related]
63. [Effect of obzidan on hemodynamics in persons with a hereditary risk of hypertension]. Titkov IuS; Minkin SR Vrach Delo; 1988 Oct; (10):3-5. PubMed ID: 3218191 [No Abstract] [Full Text] [Related]
64. [Comparative evaluation of the hemodynamic effect of a single administration of cordanum and obzidan in patients with arterial hypertension]. Brin VB; Zonis BIa Kardiologiia; 1983 Apr; 23(4):104-5. PubMed ID: 6688103 [No Abstract] [Full Text] [Related]
65. [A case of recurrent myocardial infarction after discontinuation of the treatment with beta adrenergic receptor blockaders]. Fushteĭ IM; Torbin ES; Tatarintseva NP Sov Med; 1988; (7):117-8. PubMed ID: 3227445 [No Abstract] [Full Text] [Related]
66. [Imolamine in myocardial infarct: various considerations on 34 treated cases]. Caporicci D Clin Ter; 1976 May; 77(4):357-83. PubMed ID: 1009742 [No Abstract] [Full Text] [Related]
67. [Psycho-physiologic study on the behavior of hemodynamic circulatory parameters in various task situations prior to and following intravenous administration of propranolol]. Schmidt TH; Schonecke OW; Herrmann JM; Krull F; Selbmann HK; Schäfer N; von Uexküll T; Werner I Verh Dtsch Ges Inn Med; 1975; 81():1747-50. PubMed ID: 1227078 [No Abstract] [Full Text] [Related]
68. [Evaluation of treatment results in myocardial infarct patients using nitrates depending on their mode of administration]. Kesler DF; Volikov OIu Klin Med (Mosk); 1984 Mar; 62(3):38-42. PubMed ID: 6716928 [No Abstract] [Full Text] [Related]
69. Withdrawal of propranolol and myocardial infarction. Nellen M Lancet; 1973 Mar; 1(7802):558. PubMed ID: 4119996 [No Abstract] [Full Text] [Related]
70. Propranolol in threatened myocardial infarction. Fox KA; Oliver MF Lancet; 1979 Mar; 1(8115):555. PubMed ID: 85139 [No Abstract] [Full Text] [Related]
71. Myocardial infarction during asthmatic attack induced by ingestion of propranolol. Millar AB J R Soc Med; 1982 Aug; 75(8):661-2. PubMed ID: 7108886 [No Abstract] [Full Text] [Related]
72. [Effect of obzidan and nitroglycerin on heart chamber function in acute myocardial infarct (based on echocardiographic data)]. Golikov AP; Charchoglian RA; Levshunov SP; Fishchenko AD Sov Med; 1985; (10):67-72. PubMed ID: 3936196 [No Abstract] [Full Text] [Related]
73. [Pharmacodynamic characteristics of a test using intravenous obzidan administration in patients with myocardial infarct]. Parkhomenko AN Vrach Delo; 1988 Dec; (12):8-11. PubMed ID: 3245180 [No Abstract] [Full Text] [Related]
74. [Intravenous administration of propranolol in the acute period of myocardial infarct]. Gratsianskiĭ NA; Karpov IuA; Evdokimov VV; Bunaeva VE Ter Arkh; 1980; 52(10):33-9. PubMed ID: 7444780 [No Abstract] [Full Text] [Related]
75. [Effectiveness of obzidan in patients with a history of myocardial infarct]. Il'iash MG Vrach Delo; 1988 Mar; (3):47-9. PubMed ID: 3394297 [No Abstract] [Full Text] [Related]
76. [Experience with using obzidan in myocardial infarct]. Kuznetsov GP; Gligan LI; Zil'berman ES; Gubanova TG; Fel'dman MS Klin Med (Mosk); 1984 Mar; 62(3):35-8. PubMed ID: 6716927 [No Abstract] [Full Text] [Related]